Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Berger

Showing results (671-680 of 715) with videos related to

Pageof 72
Sort By:
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 17, 2010
Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMosL-A Fraser, L Langsetmo, C Berger, et al.
Melanoma Research|July 1, 2021
Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic melanomaAlexandra M Adams, Robert C Chick, Timothy J Vreeland, et al.
Cancer Medicine|May 13, 2021
Multi-institutional, prospective, randomized, double-blind, placebo-controlled phase IIb trial of the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high-risk melanoma patients: A subgroup analysisRobert C Chick, Mark B Faries, Diane F Hale, et al.
Archives of Surgery (Chicago, Ill. : 1960)|February 22, 2012
Frailty and delayed graft function in kidney transplant recipientsJacqueline M Garonzik-Wang, Priyanka Govindan, Jack W Grinnan, et al.
Physical Review Letters|August 18, 2025
Greater than 1000-fold Gain in a Free-Electron Laser Driven by a Laser-Plasma Accelerator with High ReliabilityS K Barber, F Kohrell, C E Doss, et al.
American Journal of Clinical Oncology|January 28, 2020
Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical TrialRoss A Abrams, Kathryn A Winter, Howard Safran, et al.
Cancer Immunology, Immunotherapy : CII|August 31, 2022
Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trialAlexandra M Adams, Elizabeth L Carpenter, Guy T Clifton, et al.
Research in Veterinary Science|February 4, 2026
Veterinary perspectives on biosecurity measures in small-scale farming systems across European countries: Results from a cross-national surveyF Duarte, J Prodanov-Radulović, B Mehmedi, et al.
Journal for Immunotherapy of Cancer|August 3, 2023
Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysisElizabeth Lee Carpenter, Spencer Van Decar, Alexandra M Adams, et al.
Nature Genetics|June 30, 2018
Genome-scale analysis identifies paralog lethality as a vulnerability of chromosome 1p loss in cancerSrinivas R Viswanathan, Marina F Nogueira, Colin G Buss, et al.
Pageof 72

Showing results (671-680 of 715) with videos related to

Sort By:
Pageof 72
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 17, 2010
Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMosL-A Fraser, L Langsetmo, C Berger, et al.
Melanoma Research|July 1, 2021
Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic melanomaAlexandra M Adams, Robert C Chick, Timothy J Vreeland, et al.
Cancer Medicine|May 13, 2021
Multi-institutional, prospective, randomized, double-blind, placebo-controlled phase IIb trial of the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high-risk melanoma patients: A subgroup analysisRobert C Chick, Mark B Faries, Diane F Hale, et al.
Archives of Surgery (Chicago, Ill. : 1960)|February 22, 2012
Frailty and delayed graft function in kidney transplant recipientsJacqueline M Garonzik-Wang, Priyanka Govindan, Jack W Grinnan, et al.
Physical Review Letters|August 18, 2025
Greater than 1000-fold Gain in a Free-Electron Laser Driven by a Laser-Plasma Accelerator with High ReliabilityS K Barber, F Kohrell, C E Doss, et al.
American Journal of Clinical Oncology|January 28, 2020
Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical TrialRoss A Abrams, Kathryn A Winter, Howard Safran, et al.
Cancer Immunology, Immunotherapy : CII|August 31, 2022
Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a randomized clinical trialAlexandra M Adams, Elizabeth L Carpenter, Guy T Clifton, et al.
Research in Veterinary Science|February 4, 2026
Veterinary perspectives on biosecurity measures in small-scale farming systems across European countries: Results from a cross-national surveyF Duarte, J Prodanov-Radulović, B Mehmedi, et al.
Journal for Immunotherapy of Cancer|August 3, 2023
Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysisElizabeth Lee Carpenter, Spencer Van Decar, Alexandra M Adams, et al.
Nature Genetics|June 30, 2018
Genome-scale analysis identifies paralog lethality as a vulnerability of chromosome 1p loss in cancerSrinivas R Viswanathan, Marina F Nogueira, Colin G Buss, et al.
Pageof 72